Tag: PharmaNews
US 25% Tariff on Indian Imports May Lead to Drug Shortages and Higher Prices in America, Say Indian Pharma Experts
India’s pharmaceutical industry has responded strongly to US President Donald Trump's plan to impose a 25% tariff on…
Cipla Q1 Results: Profit Rises 10% to ₹1,298 Crore, Revenue Grows on Strong Sales in India and Africa
Cipla, one of India’s leading pharmaceutical companies, reported a 10% rise in profit for the April–June quarter of…
Syngene Q1 Profit Soars 59% to ₹87 Crore, Driven by Strong Revenue and Tax Gains
Syngene International, a company under Biocon, reported a strong 59% increase in its net profit for the April–June…
Aurobindo Pharma Gets USFDA Approval for Generic Xarelto, Targets $447 Million US Market!
Aurobindo Pharma, a Hyderabad-based pharmaceutical company, has received final approval from the US Food and Drug Administration (USFDA)…
Why Everyone’s Talking About Natco Pharma’s Risdiplam Decision!
Natco Pharma has shared an update regarding the launch of the generic version of Risdiplam in India. The…
Morepen Labs Cracks the Chinese Market with NMPA Approval for Loratadine! What This Means for Global Pharma
Morepen Laboratories has received approval from China’s National Medical Products Administration (NMPA) for its Loratadine drug, which is…
New Hope for Cancer Patients! Zydus Lifesciences’ Apalutamide Tablets Approved by USFDA
Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to produce and…